Respiratory syncytial virus immune globulin Pregnancy and Breastfeeding Warnings
Brand names: RespiGam
Respiratory syncytial virus immune globulin Pregnancy Warnings
Respiratory syncytial virus immune globulin has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Respiratory syncytial virus immune globulin is only recommended for use during pregnancy when benefit outweighs risk.
Respiratory syncytial virus immune globulin Breastfeeding Warnings
There are no data on the excretion of respiratory syncytial virus immune globulin into human milk.
See also
References for pregnancy information
- Product Information. Respigam (respiratory syncytial virus immune globulin). Medimmune Inc. 2005.
References for breastfeeding information
- Product Information. Respigam (respiratory syncytial virus immune globulin). Medimmune Inc. 2005.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
